Recent News

• 02.12.2026 - Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer

Recent Filings

• 02.02.2026 - 3/A Initial statement of beneficial ownership of securities
• 01.29.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.26.2026 - 3 Initial statement of beneficial ownership of securities
• 12.30.2025 - 3 Initial statement of beneficial ownership of securities
• 12.30.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 12.30.2025 - 3 Initial statement of beneficial ownership of securities
• 12.30.2025 - 8-K Current report
• 12.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.23.2025 - EFFECT Notice of Effectiveness
• 12.23.2025 - 424B3 Prospectus [Rule 424(b)(3)]